Wendy Cooper

508 total citations
10 papers, 393 citations indexed

About

Wendy Cooper is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wendy Cooper has authored 10 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Wendy Cooper's work include Cancer therapeutics and mechanisms (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Wendy Cooper is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Wendy Cooper collaborates with scholars based in United States and Canada. Wendy Cooper's co-authors include Mace L. Rothenberg, Marion Cremer, Roy A. Fava, Camille Gates, David R. Spriggs, Alexander S. Townes, Jakob Dupont, A. Craig Lockhart, David H. Gültekin and Jason A. Koutcher and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and Clinical & Experimental Immunology.

In The Last Decade

Wendy Cooper

10 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Cooper United States 8 184 162 95 87 54 10 393
Brett H. Simmons United States 8 257 1.4× 201 1.2× 151 1.6× 124 1.4× 40 0.7× 9 488
Nichole Prescott United States 9 287 1.6× 232 1.4× 168 1.8× 125 1.4× 31 0.6× 9 565
Vasilios Papavasiliou Canada 12 195 1.1× 180 1.1× 55 0.6× 57 0.7× 19 0.4× 14 422
E Sivridis Greece 9 189 1.0× 152 0.9× 68 0.7× 103 1.2× 28 0.5× 19 387
Tatsuya Shimomura Japan 9 203 1.1× 173 1.1× 265 2.8× 87 1.0× 69 1.3× 37 469
Shutaro Ozawa Japan 6 263 1.4× 343 2.1× 127 1.3× 126 1.4× 46 0.9× 16 538
Greg Friberg United States 10 259 1.4× 189 1.2× 116 1.2× 95 1.1× 50 0.9× 15 488
Yasuo Ohtani Japan 12 188 1.0× 341 2.1× 131 1.4× 114 1.3× 30 0.6× 34 550
María Giselle Peters Argentina 10 300 1.6× 177 1.1× 51 0.5× 89 1.0× 37 0.7× 17 469
Edina Bugyik Hungary 13 186 1.0× 164 1.0× 89 0.9× 104 1.2× 17 0.3× 23 450

Countries citing papers authored by Wendy Cooper

Since Specialization
Citations

This map shows the geographic impact of Wendy Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Cooper more than expected).

Fields of papers citing papers by Wendy Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Cooper. The network helps show where Wendy Cooper may publish in the future.

Co-authorship network of co-authors of Wendy Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Cooper. A scholar is included among the top collaborators of Wendy Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Cooper. Wendy Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chung, Cecilia P., S. Todd Callahan, Wendy Cooper, et al.. (2015). SAT0336 Development of an Algorithm to Identify Serious Opioid Toxicity in Children. Annals of the Rheumatic Diseases. 74. 780–780. 1 indexed citations
2.
Wang‐Gillam, Andrea, William P. Tew, Jakob Dupont, et al.. (2011). A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors. Investigational New Drugs. 30(5). 1958–1961. 7 indexed citations
3.
Wang‐Gillam, Andrea, Susanne M. Arnold, Ronald M. Bukowski, et al.. (2010). A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors. Investigational New Drugs. 30(1). 266–272. 11 indexed citations
4.
Lockhart, A. Craig, Mace L. Rothenberg, Jakob Dupont, et al.. (2009). Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 28(2). 207–214. 183 indexed citations
5.
Lockhart, A. Craig, Ronald M. Bukowski, Mace L. Rothenberg, et al.. (2006). Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors. Cancer Chemotherapy and Pharmacology. 60(2). 203–209. 20 indexed citations
6.
Kobayashi, Hiroyuki, S. Gail Eckhardt, Jennifer A. Lockridge, et al.. (2005). Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 56(4). 329–336. 28 indexed citations
7.
Dupont, Jakob, Mace L. Rothenberg, David R. Spriggs, et al.. (2005). Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3029–3029. 51 indexed citations
8.
Zhu, Andrew X., Ronald Bukowski, A. Craig Lockhart, et al.. (2004). Phase 1 trial of oral MAC-321 in subjects with advanced malignant solid tumors. Journal of Clinical Oncology. 22(14_suppl). 2040–2040. 1 indexed citations
9.
Cooper, Wendy, Stephen R. Daniels, & Jennifer M.H. Loggie. (1998). Prevalence and Correlates of Blood Pressure Elevation in Children with Guillain-Barre Syndrome. Clinical Pediatrics. 37(10). 621–624. 8 indexed citations
10.
Cooper, Wendy, Roy A. Fava, Camille Gates, Marion Cremer, & Alexander S. Townes. (1992). Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clinical & Experimental Immunology. 89(2). 244–250. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026